BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9129044)

  • 1. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome.
    Thangavelu M; Finn WG; Yelavarthi KK; Roenigk HH; Samuelson E; Peterson L; Kuzel TM; Rosen ST
    Blood; 1997 May; 89(9):3371-7. PubMed ID: 9129044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: search for recurrent chromosome abnormalities.
    Batista DA; Vonderheid EC; Hawkins A; Morsberger L; Long P; Murphy KM; Griffin CA
    Genes Chromosomes Cancer; 2006 Apr; 45(4):383-91. PubMed ID: 16382449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.
    Mao X; Lillington D; Scarisbrick JJ; Mitchell T; Czepulkowski B; Russell-Jones R; Young B; Whittaker SJ
    Br J Dermatol; 2002 Sep; 147(3):464-75. PubMed ID: 12207585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large cell transformation of Sézary syndrome. A conventional and molecular cytogenetic study.
    So CC; Wong KF; Siu LL; Kwong YL
    Am J Clin Pathol; 2000 Jun; 113(6):792-7. PubMed ID: 10874879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Banding studies of chromosomes in a patient with mycosis fungoides.
    Fukuhara S; Rowley JD; Variakojis D
    Cancer; 1978 Nov; 42(5):2262-8. PubMed ID: 719606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.
    Diamandidou E; Colome-Grimmer M; Fayad L; Duvic M; Kurzrock R
    Blood; 1998 Aug; 92(4):1150-9. PubMed ID: 9694702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome.
    Limon J; Nedoszytko B; Brozek I; Hellmann A; Zajaczek S; Lubiński J; Mrózek K
    Cancer Genet Cytogenet; 1995 Aug; 83(1):75-81. PubMed ID: 7656210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.
    Nielsen PR; Eriksen JO; Wehkamp U; Lindahl LM; Gniadecki R; Fogh H; Fabricius S; Bzorek M; Ødum N; Gjerdrum LM
    Acta Derm Venereol; 2019 Dec; 99(13):1231-1236. PubMed ID: 31620804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic studies of Sézary cells.
    Berger R; Bernheim A
    Cancer Genet Cytogenet; 1987 Jul; 27(1):79-87. PubMed ID: 3581043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.
    Scarisbrick JJ; Prince HM; Vermeer MH; Quaglino P; Horwitz S; Porcu P; Stadler R; Wood GS; Beylot-Barry M; Pham-Ledard A; Foss F; Girardi M; Bagot M; Michel L; Battistella M; Guitart J; Kuzel TM; Martinez-Escala ME; Estrach T; Papadavid E; Antoniou C; Rigopoulos D; Nikolaou V; Sugaya M; Miyagaki T; Gniadecki R; Sanches JA; Cury-Martins J; Miyashiro D; Servitje O; Muniesa C; Berti E; Onida F; Corti L; Hodak E; Amitay-Laish I; Ortiz-Romero PL; Rodríguez-Peralto JL; Knobler R; Porkert S; Bauer W; Pimpinelli N; Grandi V; Cowan R; Rook A; Kim E; Pileri A; Patrizi A; Pujol RM; Wong H; Tyler K; Stranzenbach R; Querfeld C; Fava P; Maule M; Willemze R; Evison F; Morris S; Twigger R; Talpur R; Kim J; Ognibene G; Li S; Tavallaee M; Hoppe RT; Duvic M; Whittaker SJ; Kim YH
    J Clin Oncol; 2015 Nov; 33(32):3766-73. PubMed ID: 26438120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
    Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2001 Sep; 117(3):663-70. PubMed ID: 11564174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF; Newland K; McCormack C; Lade S; Prince HM
    Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome studies in mycosis fungoides.
    van Vloten WA; Pet EA; Geraedts JP
    Br J Dermatol; 1980 May; 102(5):507-13. PubMed ID: 7387897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.
    Vural S; Akay BN; Botsalı A; Atilla E; Parlak N; Okçu Heper A; Şanlı H
    Turk J Haematol; 2018 Mar; 35(1):35-41. PubMed ID: 28533196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
    Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
    J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides and Sézary syndrome.
    Espinet B; Salgado R
    Methods Mol Biol; 2013; 973():175-88. PubMed ID: 23412790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas.
    Whang-Peng J; Bunn P; Knutsen T; Schechter GP; Gazdar AF; Matthews MJ; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):575-80. PubMed ID: 312695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.